25th Annual Berkeley-Stanford Advanced Patent Law Institute
Speaking Engagement | December.05.2024 - December.06.2024
Stanford Law School, Paul Brest HallOrrick Intellectual Property Partners, Will Melehani and Gargi Talukdar, spoke at the 25th Annual Berkeley-Stanford Advanced Patent Law Institute at Stanford University on December 5-6, 2024. Will Melehani joined the panel on “A Legitimate Alternative? The Rise of Amazon Enforcement Actions,” while Gargi Talukdar discussed “Evolving Double Patenting and Its Impacts on Patent Practice.”
CLE Credits Available: Y
Practice:
- Technology & Innovation Sector
- Intellectual Property
Will Melehani Partner
San Francisco
By delving into each case’s complexities and elegantly connecting those details to a broader technical perspective, Will creatively unravels his opposition’s argument.
Will uses this approach to defend cutting edge computer, Internet, software companies and life sciences companies with great success, having prevailed in numerous subject matter eligibility challenges. Will's mastery of patent law also allows him to ensure his strategy will withstand appeal, where Will has frequently played a key role in writing and arguing the appellate briefs. Whether handling patent, trademark or trade secrets matters, Will’s creative methodology gives his clients a unique advantage.
Will is also an enthusiastic participant in Orrick's pro bono efforts, and has obtained successful results for several disadvantaged and low-income pro bono clients.
Practice:
- Intellectual Property
- Life Sciences & HealthTech
- Patents
Gargi Talukder Partner
San Francisco
Gargi’s work in protein therapeutics includes patent estate development for antibody and fusion protein therapeutics and utilizes her knowledge of the patent landscape in this area to inform strategic portfolio management. In the fields of genomics and proteomics, she has conducted diligence and developed portfolios related to the biochemistry of sequencing technologies, as well as to the associated devices and machine learning methods utilized in sequencing methods. In the field of cancer immunotherapies (immuno-oncology), she has developed portfolios related to cell-based immunotherapy approaches, including targeted immune cell therapies and immunological pathway interventions.
In addition, Gargi assists clients in providing intellectual property support for transactional matters, including diligence for mergers and acquisitions as well as financing rounds. Her technical experience is routinely called upon in helping to develop litigation strategies for complex and high-stakes trials.
Gargi has authored scientific papers in peer-reviewed publications, as well as articles discussing medical and biological research in general-interest newspapers and periodicals. Her doctoral work in Neuroscience from Stanford University focused on structure-function studies in ion channels, with an emphasis on using genetic engineering and electrophysiology to identify structural elements of potassium channels that lead to their voltage and chemical sensitivity.